Laplace Interventional

Laplace Interventional Inc. Announces Series C Financing of $22M for its Transcatheter Tricuspid Valve Technology Aphelion Capital, Engage Venture Partners, Unorthodox Ventures, JWC Venture, Features Capital, ShangBay Capital, Todd Mortier , #TTVR

Great CRT 2025 and incredible progress in the field of transcatheter tricuspid valve therapies for TR patients! Thank you Dr. Kashish Goel for presenting the Laplace Interventional TTVR’s clinical feasibility update & congratulations on being a runner up for the CRT Cardiovascular innovation award. Thanks to all our Patients who participated in the trial, Physicians, Investors, Consultants, Manufacturing Partners, and everyone at Laplace!

Congratulations Dr. Brandon M. Jones, Dr. Logan Vincent, and the entire Providence team on your 1st Laplace TTVR case! Todd Mortier Jenny Barba William Dai Ryan Spanheimer Morgan Evans Engage Venture Partners ShangBay Capital Features Capital

Very excited for our first Transcatheter Tricuspid Valve replacement with the Laplace Interventional TTVR device. Right IJ approach, very intuitive deployment. Another Pacific Northwest first at Providence St. Vincent Valve Team. Logan Vincent, MD, Ramji Iyer, Dan Oliver, Kashish Goel, Lucas Schneider, Gunnar Askegaard, Pradeep Yadav, Thomas E. Waggoner, DO, FACC, FSCAI, FSVM, RPVI, Azeem Latib, Ethan Korngold, Steven Yakubov, Tara Timothy, Laplace Interventional

Our heartfelt & sincere thanks to all the patients, physicians, investors and business partners in helping us make a difference! - Laplace Interventional Team Pradeep Yadav , Thomas E. Waggoner, Kashish Goel, Chet Rihal, Andrew Rassi, Steven Yakubov, Azeem Latib, Jenny Barba, William Dai, Todd Mortier, Morgan Evans, Steve Sigmond, ShangBay Capital, Features Capital, Engage Venture Partners,

Our heartfelt & sincere thanks to all the patients, physicians, investors and business partners in helping us make a difference! - Laplace Interventional Team Pradeep Yadav , Thomas E. Waggoner, Kashish Goel, Chet Rihal, Andrew Rassi, Steven Yakubov, Azeem Latib, Jenny Barba, William Dai, Todd Mortier, Morgan Evans, Steve Sigmond, ShangBay Capital, Features Capital, Engage Venture Partners,

We successfully performed the world’s first Laplace TTVR with in-situ RV lead for symptomatic severe tricusid regurgitation as part of the EFS! Great result with no residual TR! This marks a significant advancement for Laplace transcatheter tricuspid valve in the EFS. Thanks to our fantastic research, clinical, cath lab, anesthesia, and imaging teams! Colin Barker Daniel Munoz Vanderbilt University Medical Center Melissa Long RN, MSN, FNP-BC Natalie Jackson Ramji Iyer Dan Oliver

Laplace Interventional is looking for an individual to strengthen our Valve Manufacturing team! We've recently closed our Series B funding and have started successful clinical evaluation under the FDA's Early Feasibility Study program. We're #hiring a new Operations Technician in Plymouth, Minnesota. Apply today or share this post with your network.